Effects of the 5-HT7 receptor antagonist SB-258741 in animal models for schizophrenia

Pharmacology Biochemistry and Behavior

Volumn 71, Issue 4, 2002, Pages 655-665

  Pouzet, B ^a   Didriksen, M ^a   Arnt, J ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

5 HT7; Activity; Catalepsy; Prepulse inhibition; SB 258741; Schizophrenia; Social interaction

Indexed keywords

1 (TOLUENE 3 SULFONYL) 2 [2 (4 METHYLPIPERIDIN 1 YL)ETHYL]PYRROLIDINE; DEXAMPHETAMINE; PHENCYCLIDINE; RISPERIDONE; SB 258741; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATALEPSY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SPECIFICITY; HYPERACTIVITY; MALE; NEGATIVE SYNDROME; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SOCIAL INTERACTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; CATALEPSY; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; PIPERIDINES; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RISPERIDONE; SCHIZOPHRENIA; SEROTONIN ANTAGONISTS; SOCIAL BEHAVIOR; STARTLE REACTION; TOSYL COMPOUNDS;

ANIMALIA;

EID: 0036121257     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00744-4     Document Type: Article

References (50)

1. Pharmacological specificity of conditioned avoidance response inhibition in rats: Inhibition by neuroleptics and correlation to dopamine receptor blockade
2. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine
3. Screening models for antipsychotic drugs
4. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence
5. Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine
6. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
7. A comparative review of new antipsychotics
8. Sensorimotor gating and the neurobiology of schizophrenia: Human and animal model studies
9. Gating and habituation of the startle reflex in schizophrenic patients
10. 7 and its mRNA in rats CNS by radioligand binding and in situ hybridization histochemistry
11. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
12. Apomorphine, D-amphetamine, strychnine and yohimbine do not alter prepulse inhibition of the acoustic startle reflex
13. 7 receptors
14. Lack of sensitization to the effects of D-amphetamine and apomorphine on sensorimotor gating in rats
15. 7 receptor: Orphan found
16. 7 receptor antagonist
17. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality
18. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine, and serotonin receptor subtype selective antagonists in mice
19. The new generation of antipsychotic drugs: How atypical are they?
20. 7 receptor antagonist
21. The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat
22. Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: Effects of antipsychotics and other agents in rats
23. 1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy
24. 7 receptor regulation in the rat hypothalamus
25. 7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970)
26. 7) implicated in the regulation of mammalian circadian rhythms
27. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat
28. Dopaminergic stimulation disrupts sensorimotor gating in the rat
29. Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation
30. Effects of acute versus chronic treatment with typical or atypical antipsychotics on D-amphetamine-induced sensorimotor gating deficits in rats
31. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytriptamine-7 receptors
32. Automation of the social interaction test by a video-tracking system: Behavioural effects of repeated phencyclidine treatment
33. Phencyclidine-induced stereotyped behaviour and social isolation in rats: A possible animal model of schizophrenia
34. Effect of novel antipsychotic drugs on phencyclidine-induced strereotyped behaviour and social isolation in the rat social interaction test
35. A test of the predictive validity of animal models of schizophrenia based on phencyclidine and D-apomorphine
36. A clinician's primer on the circadian clock: Its localization, function and resetting
37. 7 receptor binding sites in rat hypothalamus
38. Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia
39. Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics
40. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients
41. Seroquel restores sensorimotor gating in phencyclidine-treated rats
42. Animal models of deficient sensorimotor gating: What we know, what we think we know, and what we hope to know soon
43. 7 receptor mediating smooth muscle relaxation in canine cerebral arteries
44. 1A receptors
45. 7 receptors in the guinea-pig brain
46. 7 receptor positively coupled to adenylyl cyclase
47. Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats
48. 7 receptor gene expression in the rat hippocampus
49. Role of dopamine in prepulse inhibition of acoustic startle
50. 7 receptors in Hela cells